Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 6/2010

01.12.2010 | Advances and Challenges in PKU

Nutritional issues in treating phenylketonuria

verfasst von: François Feillet, Carlo Agostoni

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

A phenylalanine (Phe)-restricted diet is the mainstay of phenylketonuria (PKU) treatment, and, in recent years, the nutritional management of PKU has become more complex in order to optimize patients’ growth, development and diet compliance. Dietary restriction of Phe creates a diet similar to a vegan diet, and many of the nutritional concerns and questions applicable to vegans who wish to avoid animal products are also relevant to patients with PKU. Owing to their nutritional characteristics, breast milk and breastfeeding should be given greater consideration as a useful food in patients with PKU and in those with other inborn errors of metabolism. Further key issues for consideration include the quality of the available amino acid substitutes, the neurotrophic and neuroprotective effects of added long-chain polyunsaturated fatty acids (e.g. docosahexaenoic acid), micronutrient deficiencies, bone disease and antioxidant status. Long-term dietary guidance and monitoring of the nutritional status of patients with PKU should be part of a follow-up programme that continues for life.
Literatur
Zurück zum Zitat Agostoni C, Verduci E, Fiori L, Riva E, Giovannini M (2000a) Breastfeeding rates among hyperphenylalaninemic infants. Acta Paediatr 89:366–367CrossRefPubMed Agostoni C, Verduci E, Fiori L, Riva E, Giovannini M (2000a) Breastfeeding rates among hyperphenylalaninemic infants. Acta Paediatr 89:366–367CrossRefPubMed
Zurück zum Zitat Agostoni C, Massetto N, Biasucci G et al (2000b) Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia. J Pediatr 137:504–509CrossRefPubMed Agostoni C, Massetto N, Biasucci G et al (2000b) Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia. J Pediatr 137:504–509CrossRefPubMed
Zurück zum Zitat Agostoni C, Verduci E, Massetto N, Radaelli G, Riva E, Giovannini M (2003a) Plasma long-chain polyunsaturated fatty acids and neurodevelopment through the first 12 months of life in phenylketonuria. Dev Med Child Neurol 45:257–261CrossRefPubMed Agostoni C, Verduci E, Massetto N, Radaelli G, Riva E, Giovannini M (2003a) Plasma long-chain polyunsaturated fatty acids and neurodevelopment through the first 12 months of life in phenylketonuria. Dev Med Child Neurol 45:257–261CrossRefPubMed
Zurück zum Zitat Agostoni C, Verduci E, Massetto N et al (2003b) Long term effects of long chain polyunsaturated fats in hyperphenylalaninemic children. Arch Dis Child 88:582–583CrossRefPubMed Agostoni C, Verduci E, Massetto N et al (2003b) Long term effects of long chain polyunsaturated fats in hyperphenylalaninemic children. Arch Dis Child 88:582–583CrossRefPubMed
Zurück zum Zitat Agostoni C, Harvie A, McCulloch DL et al (2006) A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria. Dev Med Child Neurol 48:207–212CrossRefPubMed Agostoni C, Harvie A, McCulloch DL et al (2006) A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria. Dev Med Child Neurol 48:207–212CrossRefPubMed
Zurück zum Zitat Agostoni C, Decsi T, Fewtrell M et al (2008) Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 46:99–110CrossRefPubMed Agostoni C, Decsi T, Fewtrell M et al (2008) Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 46:99–110CrossRefPubMed
Zurück zum Zitat Al-Qadreh A, Schulpis KH, Athanasopoulou H, Mengreli C, Skarpalezou A, Voskaki I (1998) Bone mineral status in children with phenylketonuria under treatment. Acta Paediatr 87:1162–1166CrossRefPubMed Al-Qadreh A, Schulpis KH, Athanasopoulou H, Mengreli C, Skarpalezou A, Voskaki I (1998) Bone mineral status in children with phenylketonuria under treatment. Acta Paediatr 87:1162–1166CrossRefPubMed
Zurück zum Zitat Ambroszkiewicz J, Gajewska J, Chelchowska M et al (2008) Concentration of osteoprotegerin, bone formation and resorption markers in patients with phenylketonuria (in Polish). Pol Merkuriusz Lek 25:57–60 Ambroszkiewicz J, Gajewska J, Chelchowska M et al (2008) Concentration of osteoprotegerin, bone formation and resorption markers in patients with phenylketonuria (in Polish). Pol Merkuriusz Lek 25:57–60
Zurück zum Zitat American Dietetic Association, Dietitians of Canada (2003) Position of the American Dietetic Association and Dietitians of Canada: vegetarian diets. Can J Diet Pract Res 64:62–81CrossRef American Dietetic Association, Dietitians of Canada (2003) Position of the American Dietetic Association and Dietitians of Canada: vegetarian diets. Can J Diet Pract Res 64:62–81CrossRef
Zurück zum Zitat Anderson JW, Johnstone BM, Remley DT (1999) Breast-feeding and cognitive development: a meta-analysis. Am J Clin Nutr 70:525–535PubMed Anderson JW, Johnstone BM, Remley DT (1999) Breast-feeding and cognitive development: a meta-analysis. Am J Clin Nutr 70:525–535PubMed
Zurück zum Zitat Artuch R, Colomé C, Sierra C et al (2004) A longitudinal study of antioxidant status in phenylketonuric patients. Clin Biochem 37:198–203CrossRefPubMed Artuch R, Colomé C, Sierra C et al (2004) A longitudinal study of antioxidant status in phenylketonuric patients. Clin Biochem 37:198–203CrossRefPubMed
Zurück zum Zitat Barat P, Barthe N, Redonnet-Vernhet I, Parrot F (2002) The impact of the control of serum phenylalanine levels on osteopenia in patients with phenylketonuria. Eur J Pediatr 161:687–688CrossRefPubMed Barat P, Barthe N, Redonnet-Vernhet I, Parrot F (2002) The impact of the control of serum phenylalanine levels on osteopenia in patients with phenylketonuria. Eur J Pediatr 161:687–688CrossRefPubMed
Zurück zum Zitat Bazan NG (2007) Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care 10:136–141CrossRefPubMed Bazan NG (2007) Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care 10:136–141CrossRefPubMed
Zurück zum Zitat Beblo S, Reinhardt H, Muntau AC, Mueller-Felber W, Roscher AA, Koletzko B (2001) Fish oil supplementation improves visual evoked potentials in children with phenylketonuria. Neurology 57:1488–1491PubMed Beblo S, Reinhardt H, Muntau AC, Mueller-Felber W, Roscher AA, Koletzko B (2001) Fish oil supplementation improves visual evoked potentials in children with phenylketonuria. Neurology 57:1488–1491PubMed
Zurück zum Zitat Beblo S, Reinhardt H, Demmelmair H, Muntau AC, Koletzko B (2007) Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria. J Pediatr 150:479–484CrossRefPubMed Beblo S, Reinhardt H, Demmelmair H, Muntau AC, Koletzko B (2007) Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria. J Pediatr 150:479–484CrossRefPubMed
Zurück zum Zitat Cleary MA, Feillet F, White FJ et al (2006) Randomised controlled trial of essential fatty acid supplementation in phenylketonuria. Eur J Clin Nutr 60:915–920CrossRefPubMed Cleary MA, Feillet F, White FJ et al (2006) Randomised controlled trial of essential fatty acid supplementation in phenylketonuria. Eur J Clin Nutr 60:915–920CrossRefPubMed
Zurück zum Zitat Colomé C, Sierra C, Vilaseca MA (2000) Congenital errors of metabolism: cause of oxidative stress? Med Clin (Barc) 115:111–117 Colomé C, Sierra C, Vilaseca MA (2000) Congenital errors of metabolism: cause of oxidative stress? Med Clin (Barc) 115:111–117
Zurück zum Zitat Colomé C, Artuch R, Vilaseca MA et al (2002) Ubiquinone-10 content in lymphocytes of phenylketonuric patients. Clin Biochem 35:81–84CrossRefPubMed Colomé C, Artuch R, Vilaseca MA et al (2002) Ubiquinone-10 content in lymphocytes of phenylketonuric patients. Clin Biochem 35:81–84CrossRefPubMed
Zurück zum Zitat Dagnelie PC, van Staveren WA (1994) Macrobiotic nutrition and child health: results of a population-based, mixed-longitudinal cohort study in The Netherlands. Am J Clin Nutr 59(5 Suppl):1187S–1196SPubMed Dagnelie PC, van Staveren WA (1994) Macrobiotic nutrition and child health: results of a population-based, mixed-longitudinal cohort study in The Netherlands. Am J Clin Nutr 59(5 Suppl):1187S–1196SPubMed
Zurück zum Zitat Fusco D, Colloca G, Lo Monaco MR, Cesari M (2007) Effects of antioxidant supplementation on the aging process. Clin Interv Aging 2:377–387PubMed Fusco D, Colloca G, Lo Monaco MR, Cesari M (2007) Effects of antioxidant supplementation on the aging process. Clin Interv Aging 2:377–387PubMed
Zurück zum Zitat Galli C, Agostoni C, Mosconi C, Riva E, Salari PC, Giovannini M (1991) Reduced plasma C-20 and C-22 polyunsaturated fatty acids in children with phenylketonuria during dietary intervention. J Pediatr 119:562–567CrossRefPubMed Galli C, Agostoni C, Mosconi C, Riva E, Salari PC, Giovannini M (1991) Reduced plasma C-20 and C-22 polyunsaturated fatty acids in children with phenylketonuria during dietary intervention. J Pediatr 119:562–567CrossRefPubMed
Zurück zum Zitat Gutteridge JM, Halliwell B (2000) Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci 899:136–147CrossRefPubMed Gutteridge JM, Halliwell B (2000) Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci 899:136–147CrossRefPubMed
Zurück zum Zitat Huner G, Baykal T, Demir F, Demirkol M (2005) Breastfeeding experience in inborn errors of metabolism other than phenylketonuria. J Inherit Metab Dis 28:457–465CrossRefPubMed Huner G, Baykal T, Demir F, Demirkol M (2005) Breastfeeding experience in inborn errors of metabolism other than phenylketonuria. J Inherit Metab Dis 28:457–465CrossRefPubMed
Zurück zum Zitat Hvas AM, Nexo E, Nielsen JB (2006) Vitamin B12 and vitamin B6 supplementation is needed among adults with phenylketonuria (PKU). J Inherit Metab Dis 29:47–53CrossRefPubMed Hvas AM, Nexo E, Nielsen JB (2006) Vitamin B12 and vitamin B6 supplementation is needed among adults with phenylketonuria (PKU). J Inherit Metab Dis 29:47–53CrossRefPubMed
Zurück zum Zitat Karlsson KM, Karlsson C, Ahlborg HG, Valdimarsson O, Ljunghall S, Obrant KJ (2003) Bone turnover responses to changed physical activity. Calcif Tissue Int 72:675–680CrossRefPubMed Karlsson KM, Karlsson C, Ahlborg HG, Valdimarsson O, Ljunghall S, Obrant KJ (2003) Bone turnover responses to changed physical activity. Calcif Tissue Int 72:675–680CrossRefPubMed
Zurück zum Zitat Koletzko B, Lien E, Agostoni C et al (2008) The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 36:5–14CrossRefPubMed Koletzko B, Lien E, Agostoni C et al (2008) The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 36:5–14CrossRefPubMed
Zurück zum Zitat MacDonald A, Ferguson C, Rylance G et al (2003) Are tablets a practical source of protein substitute in phenylketonuria? Arch Dis Child 88:327–329CrossRefPubMed MacDonald A, Ferguson C, Rylance G et al (2003) Are tablets a practical source of protein substitute in phenylketonuria? Arch Dis Child 88:327–329CrossRefPubMed
Zurück zum Zitat MacDonald A, Lilburn M, Cochrane B et al (2004) A new, low-volume protein substitute for teenagers and adults with phenylketonuria. J Inherit Metab Dis 27:127–135CrossRefPubMed MacDonald A, Lilburn M, Cochrane B et al (2004) A new, low-volume protein substitute for teenagers and adults with phenylketonuria. J Inherit Metab Dis 27:127–135CrossRefPubMed
Zurück zum Zitat MacDonald A, Depondt E, Evans S et al (2006a) Breastfeeding in IMD. J Inherit Metab Dis 29:299–303CrossRefPubMed MacDonald A, Depondt E, Evans S et al (2006a) Breastfeeding in IMD. J Inherit Metab Dis 29:299–303CrossRefPubMed
Zurück zum Zitat MacDonald A, Lilburn M, Davies P et al (2006b) ‘Ready to drink’ protein substitute is easier is for people with phenylketonuria. J Inherit Metab Dis 29:526–531CrossRefPubMed MacDonald A, Lilburn M, Davies P et al (2006b) ‘Ready to drink’ protein substitute is easier is for people with phenylketonuria. J Inherit Metab Dis 29:526–531CrossRefPubMed
Zurück zum Zitat Mangels AR, Messina V (2001) Considerations in planning vegan diets: infants. J Am Diet Assoc 101:670–677CrossRefPubMed Mangels AR, Messina V (2001) Considerations in planning vegan diets: infants. J Am Diet Assoc 101:670–677CrossRefPubMed
Zurück zum Zitat McCarty MF (2001) Does a vegan diet reduce risk for Parkinson’s disease? Med Hypotheses 57:318–323CrossRefPubMed McCarty MF (2001) Does a vegan diet reduce risk for Parkinson’s disease? Med Hypotheses 57:318–323CrossRefPubMed
Zurück zum Zitat Messina V, Mangels AR (2001) Considerations in planning vegan diets: children. J Am Diet Assoc 101:661–669CrossRefPubMed Messina V, Mangels AR (2001) Considerations in planning vegan diets: children. J Am Diet Assoc 101:661–669CrossRefPubMed
Zurück zum Zitat Millet P, Vilaseca MA, Valls C et al (2005) Is deoxypyridinoline a good resorption marker to detect osteopenia in phenylketonuria? Clin Biochem 38:1127–1132CrossRefPubMed Millet P, Vilaseca MA, Valls C et al (2005) Is deoxypyridinoline a good resorption marker to detect osteopenia in phenylketonuria? Clin Biochem 38:1127–1132CrossRefPubMed
Zurück zum Zitat Modan-Moses D, Vered I, Schwartz G et al (2007) Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis 30:202–208CrossRefPubMed Modan-Moses D, Vered I, Schwartz G et al (2007) Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis 30:202–208CrossRefPubMed
Zurück zum Zitat Moseley K, Koch R, Moser AB (2002) Lipid status and long-chain polyunsaturated fatty acid concentrations in adults and adolescents with phenylketonuria on phenylalanine-restricted diet. J Inherit Metab Dis 25:56–64CrossRefPubMed Moseley K, Koch R, Moser AB (2002) Lipid status and long-chain polyunsaturated fatty acid concentrations in adults and adolescents with phenylketonuria on phenylalanine-restricted diet. J Inherit Metab Dis 25:56–64CrossRefPubMed
Zurück zum Zitat Praticò D (2008) Evidence of oxidative stress in Alzheimer’s disease brain and antioxidant therapy: lights and shadows. Ann N Y Acad Sci 1147:70–78CrossRefPubMed Praticò D (2008) Evidence of oxidative stress in Alzheimer’s disease brain and antioxidant therapy: lights and shadows. Ann N Y Acad Sci 1147:70–78CrossRefPubMed
Zurück zum Zitat Porta F, Roato I, Mussa A et al (2008) Increased spontaneous osteoclastogenesis from peripheral blood mononuclear cells in phenylketonuria. J Inherit Metab Dis, epub ahead of print Porta F, Roato I, Mussa A et al (2008) Increased spontaneous osteoclastogenesis from peripheral blood mononuclear cells in phenylketonuria. J Inherit Metab Dis, epub ahead of print
Zurück zum Zitat Rake JP, Visser G, Huismans D et al (2003) Bone mineral density in children, adolescents and adults with glycogen storage disease type Ia: a cross-sectional and longitudinal study. J Inherit Metab Dis 26:371–384CrossRefPubMed Rake JP, Visser G, Huismans D et al (2003) Bone mineral density in children, adolescents and adults with glycogen storage disease type Ia: a cross-sectional and longitudinal study. J Inherit Metab Dis 26:371–384CrossRefPubMed
Zurück zum Zitat Riva E, Agostoni C, Biasucci G et al (1996) Early breastfeeding is linked to higher intelligence quotient scores in dietary treated phenylketonuric children. Acta Paediatr 85:56–58CrossRefPubMed Riva E, Agostoni C, Biasucci G et al (1996) Early breastfeeding is linked to higher intelligence quotient scores in dietary treated phenylketonuric children. Acta Paediatr 85:56–58CrossRefPubMed
Zurück zum Zitat Rohr FJ, Munier AW, Levy HL (2001) Acceptability of a new modular protein substitute for the dietary treatment of phenylketonuria. J Inherit Metab Dis 24:623–630CrossRefPubMed Rohr FJ, Munier AW, Levy HL (2001) Acceptability of a new modular protein substitute for the dietary treatment of phenylketonuria. J Inherit Metab Dis 24:623–630CrossRefPubMed
Zurück zum Zitat Rutherford P, Poustie VJ (2005) Protein substitute for children and adults with phenylketonuria. Cochrane Database Syst Rev 4:CD004731PubMed Rutherford P, Poustie VJ (2005) Protein substitute for children and adults with phenylketonuria. Cochrane Database Syst Rev 4:CD004731PubMed
Zurück zum Zitat Schönau E, Schwahn B, Rauch F (2002) The muscle-bone relationship: methods and management—perspectives in glycogen storage disease. Eur J Pediatr 161:S50–S52PubMed Schönau E, Schwahn B, Rauch F (2002) The muscle-bone relationship: methods and management—perspectives in glycogen storage disease. Eur J Pediatr 161:S50–S52PubMed
Zurück zum Zitat Schulpis KH, Tsakiris S, Karikas GA, Moukas M, Behrakis P (2003) Effect of diet on plasma total antioxidant status in phenylketonuric patients. Eur J Clin Nutr 57:383–387CrossRefPubMed Schulpis KH, Tsakiris S, Karikas GA, Moukas M, Behrakis P (2003) Effect of diet on plasma total antioxidant status in phenylketonuric patients. Eur J Clin Nutr 57:383–387CrossRefPubMed
Zurück zum Zitat Schulpis KH, Karakonstantakis T, Bartzeliotou A, Karikas GA, Papassotiriou I (2004) The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet. Clin Nutr 23:401–407CrossRefPubMed Schulpis KH, Karakonstantakis T, Bartzeliotou A, Karikas GA, Papassotiriou I (2004) The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet. Clin Nutr 23:401–407CrossRefPubMed
Zurück zum Zitat Schulpis KH, Tsakiris S, Traeger-Synodinos J, Papassotiriou I (2005) Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria. Clin Biochem 38:239–242CrossRefPubMed Schulpis KH, Tsakiris S, Traeger-Synodinos J, Papassotiriou I (2005) Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria. Clin Biochem 38:239–242CrossRefPubMed
Zurück zum Zitat Schwahn B, Mokov E, Scheidhauer K, Lettgen B, Schönau E (1998) Decreased trabecular bone mineral density in patients with phenylketonuria measured by peripheral quantitative computed tomography. Acta Paediatr 87:61–63CrossRefPubMed Schwahn B, Mokov E, Scheidhauer K, Lettgen B, Schönau E (1998) Decreased trabecular bone mineral density in patients with phenylketonuria measured by peripheral quantitative computed tomography. Acta Paediatr 87:61–63CrossRefPubMed
Zurück zum Zitat Schwahn B, Rauch F, Wendel U, Schönau E (2002) Low bone mass in glycogen storage disease type 1 is associated with reduced muscle force and poor metabolic control. J Pediatr 141:350–356CrossRefPubMed Schwahn B, Rauch F, Wendel U, Schönau E (2002) Low bone mass in glycogen storage disease type 1 is associated with reduced muscle force and poor metabolic control. J Pediatr 141:350–356CrossRefPubMed
Zurück zum Zitat Sirtori LR, Dutra-Filho CS, Fitarelli D et al (2005) Oxidative stress in patients with phenylketonuria. Biochim Biophys Acta 1740:68–73PubMed Sirtori LR, Dutra-Filho CS, Fitarelli D et al (2005) Oxidative stress in patients with phenylketonuria. Biochim Biophys Acta 1740:68–73PubMed
Zurück zum Zitat Sitta A, Barschak AG, Deon M et al (2006) Investigation of oxidative stress parameters in treated phenylketonuric patients. Metab Brain Dis 21:287–296CrossRefPubMed Sitta A, Barschak AG, Deon M et al (2006) Investigation of oxidative stress parameters in treated phenylketonuric patients. Metab Brain Dis 21:287–296CrossRefPubMed
Zurück zum Zitat van Bakel MM, Printzen G, Wermuth B, Wiesmann UN (2000) Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients. Am J Clin Nutr 72:976–981PubMed van Bakel MM, Printzen G, Wermuth B, Wiesmann UN (2000) Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients. Am J Clin Nutr 72:976–981PubMed
Zurück zum Zitat van Rijn M, Bekhof J, Dijkstra T, Smit PG, Moddermam P, van Spronsen FJ (2003) A different approach to breast-feeding of the infant with phenylketonuria. Eur J Pediatr 162:323–326PubMed van Rijn M, Bekhof J, Dijkstra T, Smit PG, Moddermam P, van Spronsen FJ (2003) A different approach to breast-feeding of the infant with phenylketonuria. Eur J Pediatr 162:323–326PubMed
Zurück zum Zitat Verduci E, Agostoni C, Biondi ML, Radaelli G, Giovannini M, Riva E (2004) Apolipoprotein B gene polymorphism and plasma lipid levels in phenylketonuric children. Prostaglandins Leukot Essent Fatty Acids 71:117–120CrossRefPubMed Verduci E, Agostoni C, Biondi ML, Radaelli G, Giovannini M, Riva E (2004) Apolipoprotein B gene polymorphism and plasma lipid levels in phenylketonuric children. Prostaglandins Leukot Essent Fatty Acids 71:117–120CrossRefPubMed
Zurück zum Zitat Wajner M, Latini A, Wyse AT, Dutra-Filho CS (2004) The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis 27:427–448CrossRefPubMed Wajner M, Latini A, Wyse AT, Dutra-Filho CS (2004) The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis 27:427–448CrossRefPubMed
Metadaten
Titel
Nutritional issues in treating phenylketonuria
verfasst von
François Feillet
Carlo Agostoni
Publikationsdatum
01.12.2010
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 6/2010
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9043-4

Weitere Artikel der Ausgabe 6/2010

Journal of Inherited Metabolic Disease 6/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.